Singapore markets close in 2 hours 25 minutes

Straits Times Index
3,299.02
+8.32(+0.25%)
Nikkei
38,179.46
-49.65(-0.13%)
Hang Seng
19,045.67
+81.99(+0.43%)
FTSE 100
8,433.76
+261.61(+3.20%)
Bitcoin USD
61,188.96
+194.30(+0.32%)
CMC Crypto 200
1,260.32
+0.12(+0.01%)

Ikena Oncology, Inc. (IKNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

1.2900

-0.0600

(-4.44%)

At close: 04:00PM EDT

1.3400

+0.05

(+3.88%)

After hours:

04:22PM EDT

Trade prices are not sourced from all markets

News

Simply Wall St.
Ikena Oncology Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Ikena Oncology ( NASDAQ:IKNA ) Full Year 2023 Results Key Financial Results Net loss: US$68.2m (flat on FY 2022...
Zacks
Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Ikena Oncology, Inc. (IKNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks
Down -33.01% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround
Ikena Oncology, Inc. (IKNA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.